Kineret
What Kineret is used for
Rheumatoid Arthritis (RA) Kineret is indicated in adults for the treatment of the signs and symptoms of RA in combination with methotrexate, with an inadequate response to methotrexate alone. COVID-19 Kineret is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (suPAR) … (the exact criteria are in the official EMA product information).
Approved use, as published by the European Medicines Agency.
Key facts
- Brand
- Kineret
- Active substance
- anakinra
- Disease area
- Arthritis, Rheumatoid; COVID-19 virus infection
- Medicine group
- Immunosuppressants
- ATC code
- L04AC03
- Marketing authorisation holder
- Swedish Orphan Biovitrum AB (publ)
- Authorised in the EU since
- 2002
Official information
In the USA
Same active substance: Kineret
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Kineret used for?
Rheumatoid Arthritis (RA) Kineret is indicated in adults for the treatment of the signs and symptoms of RA in combination with methotrexate, with an inadequate response to methotrexate alone. COVID-19 Kineret is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (suPAR) … (the exact criteria are in the official EMA product information).
What is the active substance in Kineret?
Kineret contains anakinra.
Who makes Kineret?
The EU marketing authorisation holder is Swedish Orphan Biovitrum AB (publ).
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU